The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

dDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, China ...

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

A genetic screening test can be a powerful tool for understanding your inherited risk of developing certain diseases.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

The group has already helped pass bills in Arkansas and Oklahoma, and is supporting bills introduced in Florida, Mississippi, and Tennessee.

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

The “Married … With Children” star was just 36 when a routine MRI in 2008 revealed early-stage breast cancer. Finding out she ...

In the United States, breast cancer is the most common cancer diagnosed among women. In Texas, more than 22,000 women were expected to be diagnosed with breast cancer in 2025, according to the Texas ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...